LAMP2: what the two-year prevention result measured
Percentage developing myopia during follow-up · scale 0–100%
0.05% atropine28.4% · 33/116
0.01% atropine45.9% · 56/122
Placebo53% · 61/115
0%50%100%
0.05% versus placebo: 24.6 percentage points lower95% confidence interval: 12.0 to 36.4 points. The 0.01%-versus-placebo difference was not statistically significant.
Yam et al., JAMA 2023. Hong Kong; 474 nonmyopic children aged 4–9 randomized; 353 completed two years. Bars show reported two-year myopia incidence with outcome denominators. This selected trial does not establish permanent prevention or a prescription for another child. Sources: [3] ·
